Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3067% below fair value
$0.71+0.08 (+12.14%)
Close on Nov 18, 2026Market cap $5.36MP/E –Yield –
Cerenome revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cerenome's revenue for the twelve months ending Jun 30, 2026 was $4.20M, down 21.0% year over year. For fiscal 2025 it was $5.21M, down 10.5% from the year before. Over ten years it grew -4.2% a year on average. The highest annual figure on record is $8.71M in fiscal 2012.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.21M | -10.5% |
| FY2024 | Dec 31, 2024 | $5.82M | +18.5% |
| FY2023 | Dec 31, 2023 | $4.91M | +33.8% |
| FY2018 | Dec 31, 2018 | $3.67M | +36.5% |
| FY2017 | Dec 31, 2017 | $2.69M | -42.2% |
| FY2016 | Dec 31, 2016 | $4.66M | -3.8% |
| FY2015 | Dec 31, 2015 | $4.84M | -2.3% |
| FY2014 | Dec 31, 2014 | $4.95M | -30.5% |
| FY2013 | Dec 31, 2013 | $7.12M | -18.2% |
| FY2012 | Dec 31, 2012 | $8.71M | +9.1% |
| FY2011 | Dec 31, 2011 | $7.98M | -3.3% |
| FY2010 | Dec 31, 2010 | $8.25M | +41.4% |
| FY2009 | Dec 31, 2009 | $5.84M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $411.00K | -70.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.03M | -2.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.37M | -3.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.40M | -4.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.39M | +8.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.06M | -36.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.41M | +100.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.46M | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.28M | +75.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.68M | +153.3% |
| Q1 FY2019 | Mar 31, 2019 | $703.00K | +50.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.42M | +46.7% |
| Q1 FY2018 | Mar 31, 2018 | $731.00K | +23.7% |
| Q4 FY2017 | Dec 31, 2017 | $662.00K | -54.8% |
| Q3 FY2017 | Sep 30, 2017 | $467.00K | -36.1% |
| Q2 FY2017 | Jun 30, 2017 | $969.00K | -13.9% |
| Q1 FY2017 | Mar 31, 2017 | $591.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $731.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $1.13M | – |
See a number that looks wrong?